Aveanna Healthcare Holdings Inc. - Laporan Laba Rugi (TTM)

Aveanna Healthcare Holdings Inc.
US ˙ NasdaqGS ˙ US05356F1057

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Aveanna Healthcare Holdings Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2021
01-02
2021
04-03
2021
07-03
2021
10-02
2022
01-01
2022
04-02
2022
07-02
2022
10-01
2022
12-31
2023
04-01
2023
07-01
2023
09-30
2023
12-30
2024
03-30
2024
06-29
2024
09-28
2024
12-28
2025
03-29
2025
06-28
Revenue 1,495 1,557 1,642 1,687 1,679 1,712 1,719 1,751 1,788 1,804 1,833 1,868 1,895 1,919 1,952 1,983 2,025 2,093 2,178
Change (%) 4.14 5.43 2.76 -0.49 1.99 0.40 1.85 2.12 0.89 1.61 1.91 1.48 1.28 1.72 1.59 2.07 3.39 4.04
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 1,041 1,078 1,123 1,143 1,136 1,156 1,165 1,202 1,234 1,251 1,269 1,292 1,300 1,323 1,353 1,371 1,389 1,420 1,452
Change (%) 3.63 4.13 1.75 -0.56 1.78 0.73 3.17 2.72 1.32 1.50 1.76 0.62 1.76 2.27 1.37 1.29 2.22 2.26
% of Revenue 69.60 69.26 68.41 67.74 67.69 67.55 67.77 68.65 69.05 69.35 69.27 69.17 68.58 68.91 69.28 69.13 68.61 67.83 66.67
Gross Operating Profit 455 479 519 544 542 556 554 549 553 553 563 576 595 597 600 612 636 673 726
Change (%) 5.31 8.35 4.94 -0.34 2.42 -0.28 -0.93 0.80 -0.07 1.85 2.25 3.42 0.23 0.50 2.07 3.80 5.93 7.80
% of Revenue 30.40 30.74 31.59 32.26 32.31 32.45 32.23 31.35 30.95 30.65 30.73 30.83 31.42 31.09 30.72 30.87 31.39 32.17 33.33
SG&A 346 357 392 403 410 439 454 475 477 475 467 463 472 467 467 469 477 488 495
Change (%) 3.26 9.54 2.97 1.76 6.96 3.44 4.63 0.51 -0.56 -1.60 -0.92 1.94 -1.04 0.13 0.35 1.70 2.33 1.31
% of Revenue 23.15 22.96 23.85 23.90 24.44 25.63 26.41 27.13 26.70 26.32 25.49 24.78 24.89 24.32 23.94 23.65 23.56 23.32 22.71
R&D
Change (%)
% of Revenue
OpEx 1,403 1,453 1,532 1,564 1,567 1,616 1,641 1,700 1,735 1,747 1,756 1,772 1,785 1,804 1,834 1,855 1,877 1,916 1,955
Change (%) 3.54 5.44 2.08 0.19 3.16 1.51 3.64 2.04 0.69 0.51 0.89 0.75 1.07 1.65 1.14 1.18 2.11 2.00
% of Revenue 93.85 93.31 93.32 92.70 93.33 94.41 95.45 97.13 97.05 96.87 95.82 94.87 94.18 93.99 93.92 93.51 92.70 91.55 89.75
Operating Income 92 104 110 123 112 96 78 50 53 57 77 96 110 115 119 129 148 177 223
Change (%) 13.27 5.30 12.27 -9.04 -14.47 -18.27 -35.85 4.91 7.30 35.49 25.24 14.94 4.68 2.83 8.46 14.85 19.65 26.19
% of Revenue 6.15 6.69 6.68 7.30 6.67 5.59 4.55 2.87 2.95 3.13 4.18 5.13 5.82 6.01 6.08 6.49 7.30 8.45 10.25
Interest Expense -88 -80 -77 -69 -56 -33 -33 -30 -22 -69 -83 -112 -170 -163 -150 -199 -164 -168 -187
Change (%) -8.97 -4.06 -9.52 -19.72 -41.18 0.84 -8.07 -26.45 209.39 20.52 34.42 51.96 -4.26 -7.98 32.75 -17.70 2.60 11.12
% of Revenue -5.88 -5.14 -4.67 -4.12 -3.32 -1.91 -1.92 -1.74 -1.25 -3.83 -4.55 -6.00 -8.98 -8.49 -7.68 -10.04 -8.10 -8.03 -8.58
Net Income -57 -89 -10 -1 -117 -98 -573 -550 -662 -719 -220 -347 -135 -114 -125 -66 -11 5 19
Change (%) 55.81 -88.66 -94.20 19,941.78 -16.69 487.29 -3.88 20.27 8.66 -69.43 57.62 -61.18 -15.48 10.28 -47.49 -83.40 -149.74 241.34
% of Revenue -3.82 -5.71 -0.61 -0.03 -6.97 -5.70 -33.32 -31.44 -37.03 -39.89 -12.00 -18.56 -7.10 -5.92 -6.42 -3.32 -0.54 0.26 0.85

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista